Form 4 for HIPO Hippo Holdings Inc.
Accepted 2024-03-26 00:00:00 ET · period of report 2024-03-22 · accession 0001562180-24-002999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-26 | 2024-03-22 | HIPO | Harry Yuval | Chief Revenue Off | M - OptEx | $6.45 | +13.2K | 150.8K | +10% | +$85.1K |
| DM | 2024-03-26 | 2024-03-22 | HIPO | Harry Yuval | Chief Revenue Off | S - Sale+OE | $17.20 | -14.9K | 145.2K | -9% | -$256.9K |
| DM | 2024-03-26 | 2024-03-22 | HIPO | Harry Yuval | Chief Revenue Off | M - OptEx | $0.00 | -13.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-22 | M | A | 3,333 | $8.50 | 154,102 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-22 | M | A | 5,998 | $4.00 | 160,100 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-22 | M | A | 3,855 | $8.50 | 150,769 | D | — | — | |
| 4 | Common | Common Stock | 2024-03-22 | S | D | 1,752 | $17.25 | 158,348 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price. |
| 5 | Common | Common Stock | 2024-03-22 | S | D | 5,998 | $17.19 | 152,350 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price. |
| 6 | Common | Common Stock | 2024-03-22 | S | D | 3,333 | $17.20 | 149,017 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price. |
| 7 | Common | Common Stock | 2024-03-22 | S | D | 3,855 | $17.18 | 145,162 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price. (F5) Includes 94,719 RSUs. |
| 8 | Derivative | Stock Options (Right to buy) | 2024-03-22 | M | D | 5,998 | $0.00 | 0 | D | $4.00 · — to 2028-01-23 | 5,998 Common Stock | (F8) The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022. |
| 9 | Derivative | Stock Options (Right to buy) | 2024-03-22 | M | D | 3,333 | $0.00 | 0 | D | $8.50 · — to 2029-05-14 | 3,333 Common Stock | (F7) The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023. |
| 10 | Derivative | Stock Options (Right to buy) | 2024-03-22 | M | D | 3,855 | $0.00 | 0 | D | $8.50 · — to 2029-01-22 | 3,855 Common Stock | (F6) The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023. |